Literature DB >> 21528356

Preparation of decellularized and crosslinked artery patch for vascular tissue-engineering application.

Yilin Zhao1, Zhigang Zhang, Jinling Wang, Ping Yin, Yu Wang, Zhenyu Yin, Jianyin Zhou, Gang Xu, Yun Liu, Zhigang Deng, Maochuan Zhen, Wugeng Cui, Zhongchen Liu.   

Abstract

There is an urgent clinical need of tissue-engineering (TE) vascular grafts, so this study was for developing a fast and simple way of producing TE vascular scaffold. The TE vascular scaffold was prepared with pepsin, DNase and RNase enzymatic decellularization and crosslinked with 0.1, 1, 5% glutaraldehyde (GA), respectively. The samples were underwent analyses of burst pressure; suture strength; cytotoxicity; enzymatic degradation in vitro; degradation in vivo; rehydration; biocompatibilities detected with hematoxylin and eosin (H&E), scan electron microscope, immunohistochemistry both in vivo and in vitro; macrophage infiltration and calcification using Von Kossa staining. After being decellularized the scaffold had a complete removal of cellular components, an intact collagen structure. The burst pressure and suture strength were similar to native artery. 0.1% GA crosslinked scaffold showed less cytotoxicity than 1 and 5% GA groups (P < 0.05) and was resistance to enzymatic degradation in vitro. Once being implanted, 0.1% GA group was resistant to degradation and formed endothelium, smooth muscle and adventitia with few macrophages infiltration. However, there appeared calcification in implants compared with that in native artery. This study demonstrated that DVPs producing methods by enzymatic decellularizing and crosslinking with 0.1% GA could be used for clinical TE vascular graft manufacture.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21528356     DOI: 10.1007/s10856-011-4326-3

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  32 in total

1.  In vivo autologous recellularization of a tissue-engineered heart valve: are bone marrow mesenchymal stem cells the best candidates?

Authors:  Andre Vincentelli; Fabrice Wautot; Francis Juthier; Olivier Fouquet; Delphine Corseaux; Sylvestre Marechaux; Thierry Le Tourneau; Olivier Fabre; Sophie Susen; Eric Van Belle; Frederic Mouquet; Christophe Decoene; Alain Prat; Brigitte Jude
Journal:  J Thorac Cardiovasc Surg       Date:  2007-07-12       Impact factor: 5.209

2.  Impact of heart valve decellularization on 3-D ultrastructure, immunogenicity and thrombogenicity.

Authors:  Jianye Zhou; Olaf Fritze; Martina Schleicher; Hans-Peter Wendel; Katja Schenke-Layland; Csaba Harasztosi; Shengshou Hu; Ulrich A Stock
Journal:  Biomaterials       Date:  2010-01-12       Impact factor: 12.479

Review 3.  Adaptation and remodeling of vascular wall; biomechanical response to hypertension.

Authors:  Kozaburo Hayashi; Takeru Naiki
Journal:  J Mech Behav Biomed Mater       Date:  2008-05-22

Review 4.  Mesenchymal stem cells: a perspective from in vitro cultures to in vivo migration and niches.

Authors:  Andrea Augello; Tobias B Kurth; Cosimo De Bari
Journal:  Eur Cell Mater       Date:  2010-09-01       Impact factor: 3.942

5.  Preliminary experience with tissue engineering of a venous vascular patch by using bone marrow-derived cells and a hybrid biodegradable polymer scaffold.

Authors:  Seung-Woo Cho; Oju Jeon; Joung Eun Lim; So-Jung Gwak; Sang-Soo Kim; Cha Yong Choi; Dong-Ik Kim; Byung-Soo Kim
Journal:  J Vasc Surg       Date:  2006-12       Impact factor: 4.268

6.  Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells.

Authors:  Toshiharu Shin'oka; Goki Matsumura; Narutoshi Hibino; Yuji Naito; Manabu Watanabe; Takeshi Konuma; Takahiko Sakamoto; Masayoshi Nagatsu; Hiromi Kurosawa
Journal:  J Thorac Cardiovasc Surg       Date:  2005-06       Impact factor: 5.209

7.  Vascular patches tissue-engineered with autologous bone marrow-derived cells and decellularized tissue matrices.

Authors:  Seung-Woo Cho; Hee Jung Park; Ju Hee Ryu; Soo Hyun Kim; Young Ha Kim; Cha Yong Choi; Min-Jae Lee; Jong-Sung Kim; In-Sung Jang; Dong-Ik Kim; Byung-Soo Kim
Journal:  Biomaterials       Date:  2005-05       Impact factor: 12.479

8.  Inhibition of aortic wall calcification in bioprosthetic heart valves by ethanol pretreatment: biochemical and biophysical mechanisms.

Authors:  C H Lee; N Vyavahare; R Zand; H Kruth; F J Schoen; R Bianco; R J Levy
Journal:  J Biomed Mater Res       Date:  1998-10

9.  Favorable effects of the detergent and enzyme extraction method for preparing decellularized bovine pericardium scaffold for tissue engineered heart valves.

Authors:  Min Yang; Chang-Zhi Chen; Xue-Ning Wang; Ya-Bin Zhu; Y John Gu
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2009-10       Impact factor: 3.368

10.  Glutaraldehyde-fixed kangaroo aortic wall tissue: histology, crosslink stability and calcification potential.

Authors:  W M L Neethling; A J Hodge; R Glancy
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2003-07-15       Impact factor: 3.368

View more
  1 in total

1.  Comparison of decellularization protocols for preparing a decellularized porcine annulus fibrosus scaffold.

Authors:  Haiwei Xu; Baoshan Xu; Qiang Yang; Xiulan Li; Xinlong Ma; Qun Xia; Yang Zhang; Chunqiu Zhang; Yaohong Wu; Yuanyuan Zhang
Journal:  PLoS One       Date:  2014-01-24       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.